shortagewatch

Home / Companies / Bausch Health

Company family · HQ CA

Bausch Health: medicine shortages

BHC · NYSE / TSX

As of 2 Nov 2026, 39 Bausch Health products have a reported shortage across 9 countries, covering 30 medicines.

Products short39rank #52 of 464
Medicines30active ingredients
Countries9/16
New in 90 days17+13 vs market pace
Typical duration3 monthsmedian so far
Manufacturing61%demand-driven 19%

Where

United States2Canada7Italy5Spain2Ireland8Belgium4Czechia8Norway1Sweden2

Which therapeutic classes

Sensory organs17Cardiovascular system3Nervous system3Cancer and immune system3Digestive tract and metabolism3Anti-infectives3Dermatologicals2Respiratory system1Blood1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Bausch HealthBausch Health: Manufacturing problem 19 (49%)49%Bausch Health: Increased demand 6 (15%)15%Bausch Health: Active ingredient shortage 1 (3%)Bausch Health: Distribution or logistics 1 (3%)Bausch Health: Commercial decision or withdrawal 2 (5%)5%Bausch Health: Other 2 (5%)5%Bausch Health: Not stated 8 (21%)21%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

05101520Dec: 2Jan ’25: 1Feb: 0FebMar: 0Apr: 0May: 1MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 1Jan ’26: 0Feb: 1FebMar: 1Apr: 0May: 1MayJun: 0Jul: 1Aug: 2AugSep: 3Oct: 12Nov: 0Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 620172018: 1020182019: 1320192020: 1420202021: 2520212022: 6420222023: 5020232024: 5320242025: 2620252026: 42026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Bausch Health39

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Bausch Health: 39 / 30Bausch Health

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Timolol, Combinations327 Jan 2025Manufacturing problem9/16
Cefprozil231 Aug 2026Commercial decision or withdrawal2/16
Megestrol25 Dec 2024Increased demand2/16
Methylnaltrexone Bromide216 Aug 2024Manufacturing problem2/16
Tretinoin2not givenNot stated1/16
Acetylcholine14 Dec 2025Manufacturing problem4/16
Atropine116 Oct 2026Manufacturing problem5/16
Besifloxacin113 Oct 2026Distribution or logistics1/16
Bimatoprost17 Sep 2026Manufacturing problem3/16
Bromfenac122 Oct 2026Increased demand3/16
Carteolol124 Jan 2024Not stated1/16
Cefadroxil118 Nov 2026Manufacturing problem1/16
Chlorothiazide110 Feb 2026Not stated1/16
Combinations111 Feb 2020Active ingredient shortage1/16
Cyclopentolate116 Oct 2026Manufacturing problem3/16
Diazepam119 Oct 2026Other7/16
Dorzolamide16 Dec 2024Manufacturing problem5/16
Fluorescein18 Oct 2026Not stated5/16
Fluorescein, Combinations11 May 2018Other1/16
Fosinopril119 Aug 2024Increased demand1/16
Fosinopril and Diuretics123 Aug 2024Increased demand1/16
Oxybuprocaine120 Oct 2026Manufacturing problem2/16
Proxymetacaine116 Oct 2026Manufacturing problem2/16
Teriflunomide11 Jul 2026Commercial decision or withdrawal4/16
Tetrabenazine119 Aug 2024Increased demand1/16
Tetracaine116 Oct 2026Manufacturing problem2/16
Tetracaine14 Nov 2026Increased demand1/16
Ticagrelor129 Sep 2026Manufacturing problem2/16
Travoprost14 Nov 2024Manufacturing problem7/16
Tropicamide128 Oct 2026Manufacturing problem5/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.